Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02056821 · ClinicalTrials.gov registry record

Hemodynamic Effects on Cerebral Autoregulation in Acute Stroke

A clinical trial of Ischemic Stroke, sponsored by Henry Ford Health System.

Completed
Registry status
88
Enrollment target
1
Study location

NCT02056821 is a study of Ischemic Stroke that has completed, run by Henry Ford Health System. The registered enrollment target is 88 participants, below the 1,462-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02056821, a study of Ischemic Stroke, has completed, sponsored by Henry Ford Health System.

COMPLETED
Registry status
88 participants
Enrollment target
1
Study location

Study Summary

This study investigates if there are hemodynamic alterations in acute stroke that predispose patients to impaired perfusion and regulation of cerebral blood flow. To test this, we will target recruitment of acute ischemic stroke patients who present to the ED within 12 hours of symptoms onset. Enrolled subjects will receive continuous noninvasive hemodynamic monitoring contemporaneous with measurements of cerebral blood flow velocities and cerebral oximetry.

Conditions Studied

Study Locations (1)

Michigan

  • Henry Ford Hospital - Detroit

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2014-02
Est. Completion 2016-05

Sponsor

Henry Ford Health System

234 total trials

What the Registry Record Tells You About NCT02056821

The ClinicalTrials.gov registry entry for NCT02056821 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,462-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (94% lower). The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT02056821 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT02056821 about?

NCT02056821 is a clinical study titled "Hemodynamic Effects on Cerebral Autoregulation in Acute Stroke". This study investigates if there are hemodynamic alterations in acute stroke that predispose patients to impaired perfusion and regulation of cerebral blood flow. To test this, we will target recruitment of acute ischemic stroke patients who present to the ED within 12 hours of symptoms onset. Enrol...

What is the current status of trial NCT02056821?

This trial is currently completed. The enrollment target is 88 participants. The study started on 2014-02. Estimated completion is 2016-05.

What conditions does trial NCT02056821 study?

This clinical trial studies the following conditions: Ischemic Stroke.

Who is sponsoring clinical trial NCT02056821?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02056821 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ischemic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.